Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip S Lecane

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Targeting hypoxic cells through the DNA damage responseMonica Olcina, Philip S Lecane, Ester M Hammond
The Prostate|January 23, 2003
Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell linePhilip S Lecane, Taija M Kiviharju, Robert G Sellers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cellsTaija M Kiviharju, Philip S Lecane, Robert G Sellers, et al.
Cancer Research|December 17, 2005
Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma linesPhilip S Lecane, Mazen W Karaman, Mint Sirisawad, et al.
Molecular and Cellular Biology|November 5, 2008
ATM activation and signaling under hypoxic conditionsZuzana Bencokova, Muriel R Kaufmann, Isabel M Pires, et al.
Leukemia & Lymphoma|October 29, 2009
Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemiaThomas S Lin, Louie Naumovski, Philip S Lecane, et al.
Molecular Cancer|January 20, 2007
Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expressionZhong Wang, Philip S Lecane, Patricia Thiemann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Targeting hypoxic cells through the DNA damage responseMonica Olcina, Philip S Lecane, Ester M Hammond
The Prostate|January 23, 2003
Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell linePhilip S Lecane, Taija M Kiviharju, Robert G Sellers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cellsTaija M Kiviharju, Philip S Lecane, Robert G Sellers, et al.
Cancer Research|December 17, 2005
Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma linesPhilip S Lecane, Mazen W Karaman, Mint Sirisawad, et al.
Molecular and Cellular Biology|November 5, 2008
ATM activation and signaling under hypoxic conditionsZuzana Bencokova, Muriel R Kaufmann, Isabel M Pires, et al.
Leukemia & Lymphoma|October 29, 2009
Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemiaThomas S Lin, Louie Naumovski, Philip S Lecane, et al.
Molecular Cancer|January 20, 2007
Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expressionZhong Wang, Philip S Lecane, Patricia Thiemann, et al.
Pageof 1